Issues To Consider From The Alexion Enforcement Action
Mike Koehler identifies several issues with the SEC’s recent $21.5 million FCPA enforcement action against Alexion Pharmaceuticals.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.